Managing Influenza in the High-Risk Patient

Download All
Following a PCE Symposia Live Stream Series, an expert in infectious diseases and influenza gives his personal perspectives on influenza treatment and post-exposure chemoprophylaxis strategies in immunosuppressed adults and children including optimal use of neuraminidase inhibitors (NAIs) and baloxavir.
Paul G. Auwaerter, MD

ClinicalThought

Mitigating influenza morbidity and mortality in immunosuppressed patients requires timely preventative and therapeutic decisions. Healthcare professionals now have greater options for diagnostics and treatment.

Paul G. Auwaerter, MD Released: August 5, 2021

The decision to use antivirals for post-exposure influenza chemoprophylaxis is multifaceted. As we anticipate a resurgence of influenza activity this year, how will you leverage the expanding antiviral armamentarium for prevention?

Paul G. Auwaerter, MD Released: August 5, 2021

As we anticipate a resurgence of influenza activity this year, healthcare professionals must refocus on prevention and treatment in the pediatric population. Effective mitigation strategies can benefit both children and adults.

Paul G. Auwaerter, MD Released: August 5, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue